IM Cannabis (IMCC) EBITDA Margin (2020 - 2026)
IM Cannabis' (IMCC) quarterly EBITDA Margin came in at 19.31% in Q1 2026, down 2057.0% year-on-year from 0.99% in Q1 2025, and up 80.42% quarter-over-quarter from 98.64% in Q4 2025.
IM Cannabis (IMCC) EBITDA Margin (2020 - 2026) Analysis & Trends
IM Cannabis' EBITDA Margin history runs 7 years deep, the most recent figure standing at 19.31% for Q1 2026.
- On a quarterly basis, EBITDA Margin fell 2057.0% year-over-year to 19.31% in Q1 2026; TTM through Mar 2026 was 26.21%, a 1992.0% increase from a year earlier, with the FY2025 full-year figure at 21.17%, down 223.0% from the prior year.
- EBITDA Margin grew to 19.31% in Q1 2026 per IMCC's latest filing, from 98.64% in the prior quarter.
- Across five years, EBITDA Margin topped out at 28.87% in Q1 2023 and bottomed at 904.55% in Q3 2022.
- The 5-year median for EBITDA Margin is 25.44% (2022), against an average of 100.48%.
- Across the five-year window, EBITDA Margin plunged 83420 bps in 2022 and surged 88728 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 231.3% in 2022, then jumped by 75 bps to 56.87% in 2023, then slumped by 174 bps to 155.92% in 2024, then jumped by 37 bps to 98.64% in 2025, then soared by 80 bps to 19.31% in 2026.
- Per Business Quant, the three latest IMCC EBITDA Margin figures stand at 19.31% (Q1 2026), 98.64% (Q4 2025), and 27.9% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -19.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.31% |
| Dec 31, 2025 | -98.64% |
| Sep 30, 2025 | 27.90% |
| Jun 30, 2025 | -1.53% |
| Mar 31, 2025 | 1.26% |
| Dec 31, 2024 | -155.92% |
| Sep 30, 2024 | -7.79% |
| Jun 30, 2024 | -23.43% |
| Mar 31, 2024 | -46.67% |
| Dec 31, 2023 | -56.87% |
| Sep 30, 2023 | -17.27% |
| Jun 30, 2023 | -28.06% |
| Mar 31, 2023 | 28.87% |
| Dec 31, 2022 | -231.30% |
| Sep 30, 2022 | -904.55% |
| Jun 30, 2022 | -149.40% |
| Mar 31, 2022 | -25.44% |
| Dec 31, 2021 | -171.56% |
| Sep 30, 2021 | -70.35% |
| Jun 30, 2021 | -45.80% |